Join
Live feed
·
INSIDERFilingvia Quantisnow
Marker Therapeutics Inc. logo

SEC Form 4: Robert John Wilson bought $2,999,999 worth of Common Stock (1,714,285 units at $1.75), increasing direct ownership by 28% to 7,799,350 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRKR (Marker Therapeutics Inc.) and more on Quantisnow.